With all the proposed COVID therapies being talked about, monoclonal antibody treatment has received little attention, compared to its strong effectiveness in preventing serious disease and hospitalization. Dr. Adit Ginde is leading a team to improve uptake of this important therapy. His work is starting to catch on in statewide media.
Vitamin D is being studied as an essential factor in many diseases, including respiratory infections and COVID-19. The evidence is complex, and conclusions are difficult to draw. Dr. Ginde helps sort out the confusion in this NPR story.
Enacting firearm-related legislation alone won’t solve the problem of firearm-related injuries and deaths — nor will education, nor will engineering. We need them all — and we need the research to inform them all. We need to engage varied voices in these discussions. We need to move away from vilifying the “other side” and instead embrace the fact that all of us want to keep our friends and loved ones safe from harm.
A new $8.7 million grant from the National Institutes of Health (NIH) will fuel a statewide project to improve care of patients affected by COVID-19. Adit Ginde, MD, MPH, Professor of Emergency Medicine is leading a team of researchers from the Colorado Clinical and Translational Sciences Institute at the University of Colorado Anschutz Medical Campus to test the real-world effectiveness of monoclonal antibody treatment for high-risk COVID-19 outpatients.
Dr Vikhyat Bebarta and Dr Dickson Cheung received a $2.8 million dollar grant from the Department of Defense to develop an algorithm using a wearable device to detect COVID-19 infection. This 2500 patient study will be conducted in collaboration with Philips Healthcare, BioIntellliSense and ClinOne. If successful, early detection of COVID-19 can be accomplished via a wireless, wearable device that provides continuous monitoring for 14 days.
Dr. Comstock, in partnership with the Hoppe Lab, was awarded the EMF/NIDA Mentored Training Award in Substance Use Disorders Science Dissemination to fund their project: Defining and Addressing Barriers to Buprenorphine Prescribing in Emergency Departments Across a Healthcare System.
Parallels exist between healthcare in COVID-19 units today and military medicine on the battlefields. Kathleen Flarity knows both. The deputy director of the CU Anschutz Center for COMBAT Research shares the risks and remedies for burnout and compassion fatigue.
A new series by Rocky Mountain PBS on youth suicide highlights a recent study in 6 emergency departments across Colorado. The study was conducted through a partnership between Dr. Betz and researchers at the Program for Injury Prevention, Education & Research, the Harvard School of Public Health, and Northeastern University.
Working with gun shop owners and public health officials, Dr. Betz built a broad coalition to decrease gun suicide in a way that gets beyond traditional partisan boundaries. By creating maps of facilities that can safely store firearms, this program can help people at risk for suicide without invoking red flag laws.
Marian Betz, M.D., M.P.H. is leading a project examining the perspectives of firearm suppliers and firearm users in Colorado and Washington on these statewide firearm storage maps. The researchers will also develop an implementation toolkit for other states considering or creating firearm storage maps.
Kathleen Flarity, DNP, PhD, the Deputy Director of the COMBAT Center, was recently promoted to the Rank of Brigadier General and will serve as the interim Command Surgeon for the US Air Force Air Mobility Command (AMC).